Drugs Made In America Acquisition Stock (NASDAQ:DMAA)
Previous Close
$10.27
52W Range
$9.95 - $10.28
50D Avg
$10.18
200D Avg
$10.11
Market Cap
$344.05M
Avg Vol (3M)
$44.94K
Beta
-0.00
Div Yield
-
DMAA Company Profile
Drugs Made In America Acquisition Corp. operates as a blank check company. The Company aims to acquire one and more businesses and assets, via a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization.